{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:37:25Z","timestamp":1791398245214,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humpath.2025.106025","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:15:53Z","timestamp":1766646953000},"page":"106025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["What's new in upper gastrointestinal pathology: Key updates and evolving challenges in 2026"],"prefix":"10.1016","volume":"169","author":[{"given":"Domenika","family":"Ortiz Requena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.humpath.2025.106025_bib1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/his.12886","article-title":"Prevalence of oesophageal epidermoid metaplasia in 1048 consecutive patients and 58 patients with squamous neoplasms","volume":"68","author":"Cottreau","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2025.106025_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/modpathol.2013.100","article-title":"Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients","volume":"27","author":"Singhi","year":"2014","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2025.106025_bib3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.14309\/ajg.0000000000001225","article-title":"Esophageal epidermoid metaplasia: clinical characteristics and risk of esophageal squamous neoplasia","volume":"116","author":"Kamboj","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.106025_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152104","article-title":"Wolf in sheep's clothing - oral proliferative verrucous leukoplakia: progression with longitudinal molecular insights","volume":"63","author":"Afkhami","year":"2023","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/odi.14550","article-title":"Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features","volume":"30","author":"Herreros-Pomares","year":"2024","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.humpath.2025.106025_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12105-020-01262-9","article-title":"Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting","volume":"15","author":"Thompson","year":"2021","journal-title":"Head Neck Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.106025_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2559.2012.04283.x","article-title":"Keratin 10-positive orthokeratotic dysplasia: a new leucoplakia-type precancerous entity of the oral mucosa","volume":"61","author":"Kobayashi","year":"2012","journal-title":"Histopathology"},{"issue":"107\u2013108","key":"10.1016\/j.humpath.2025.106025_bib8","first-page":"809","article-title":"Epidermoid metaplasia of the esophagus: endoscopic feature and differential diagnosis","volume":"58","author":"Ezoe","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/his.12195","article-title":"Oesophageal hyperkeratosis: clinicopathological associations","volume":"63","author":"Taggart","year":"2013","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.humpath.2025.106025_bib10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/modpathol.2017.73","article-title":"Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia","volume":"30","author":"Singhi","year":"2017","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2025.106025_bib11","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.14309\/ajg.0000000000003041","article-title":"Clinical and biological perspectives on noncanonical esophageal squamous cell carcinoma in rare subtypes","volume":"119","author":"Pomenti","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","article-title":"AGA clinical practice guidelines on management of gastric intestinal metaplasia","volume":"158","author":"Gupta","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.humpath.2025.106025_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12935-021-01869-0","article-title":"A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk","volume":"21","author":"Wei","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG clinical guideline: diagnosis and management of gastric premalignant conditions","volume":"120","author":"Morgan","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pathol.2021.12.288","article-title":"Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study","volume":"54","author":"Lerch","year":"2022","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.humpath.2025.106025_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"issue":"5","key":"10.1016\/j.humpath.2025.106025_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/a-2529-5025","volume":"57","author":"Dinis-Ribeiro","year":"2025","journal-title":"Endoscopy"},{"issue":"8","key":"10.1016\/j.humpath.2025.106025_bib18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.MP.0000080349.37658.5E","article-title":"Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes","volume":"16","author":"Abraham","year":"2003","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00535-010-0350-1","article-title":"Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group","volume":"46","author":"Kato","year":"2011","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PAS.0b013e31815b890e","article-title":"Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia","volume":"32","author":"Park","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2025.106025_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00428-020-02846-0","article-title":"The clinicopathological and molecular features of sporadic gastric foveolar type neoplasia","volume":"477","author":"Sugai","year":"2020","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.humpath.2025.106025_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/PAS.0000000000001949","article-title":"Sporadic and familial adenomatous polyposis-associated foveolar-type adenoma of the stomach","volume":"47","author":"Naka","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2025.106025_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00000478-200210000-00004","article-title":"Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology","volume":"26","author":"Abraham","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000534571","article-title":"Gastric polyps in familial adenomatous polyposis Portuguese patients: the first Western cohort with Asian features","volume":"91","author":"Baptista","year":"2024","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.humpath.2025.106025_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PAS.0b013e31817d7ff4","article-title":"Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2025.106025_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jclinpath-2014-202553","article-title":"Some observations on pyloric gland adenoma: an uncommon and long ignored entity!","volume":"67","author":"Vieth","year":"2014","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00428-002-0750-6","article-title":"Pyloric gland adenoma: a clinico-pathological analysis of 90 cases","volume":"442","author":"Vieth","year":"2003","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000000146","article-title":"Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms","volume":"38","author":"Wood","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/path.4153","article-title":"Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum","volume":"229","author":"Matsubara","year":"2013","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.106025_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/his.12705","article-title":"Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features","volume":"67","author":"Hashimoto","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/his.13105","article-title":"Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis","volume":"70","author":"Hackeng","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106025_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2019.11.004","article-title":"Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas","volume":"97","author":"Setia","year":"2020","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2025.106025_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41379-019-0338-1","article-title":"Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology","volume":"33","author":"Ushiku","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.106025_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100719","article-title":"Diffuse cyclin D1 and SPINK1 expression in gastric oxyntic gland neoplasms: promising diagnostic markers identified using spatial transcriptome analysis","volume":"38","author":"Shinozaki-Ushiku","year":"2025","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib35","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/ibd\/izaa320","article-title":"Colitis after CAR T-cell therapy for refractory large B-cell lymphoma responds to anti-integrin therapy","volume":"27","author":"Hashim","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.humpath.2025.106025_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105791","article-title":"Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: histologic features and morphologic mimics","volume":"158","author":"Karimi","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106025_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1149450","article-title":"Case report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma","volume":"13","author":"Zundler","year":"2023","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.humpath.2025.106025_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/COC.0000000000000596","article-title":"Gastrointestinal adverse events observed after chimeric antigen receptor T-cell therapy","volume":"42","author":"Abu-Sbeih","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2025.106025_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41408-024-01167-8","article-title":"Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma","volume":"14","author":"Fortuna","year":"2024","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.humpath.2025.106025_bib40","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2025.106025_bib41","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.106025_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/his.13118","article-title":"PD-1 inhibitor gastroenterocolitis: case series and appraisal of \u2018immunomodulatory gastroenterocolitis\u2019","volume":"70","author":"Gonzalez","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.humpath.2025.106025_bib43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2559.2012.04305.x","article-title":"Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsies","volume":"61","author":"Coyne","year":"2012","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.humpath.2025.106025_bib44","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0000000000000921","article-title":"Differentiating posttransplant inflammatory bowel disease and other colitides in renal transplant patients","volume":"41","author":"Pittman","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2025.106025_bib45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.humpath.2025.106025_bib46","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"issue":"47","key":"10.1016\/j.humpath.2025.106025_bib47","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.humpath.2025.106025_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/COC.0000000000000553","article-title":"Clinical features of rituximab-associated gastrointestinal toxicities","volume":"42","author":"Mallepally","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib49","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ibd.22963","article-title":"Rituximab-associated colitis","volume":"19","author":"Bhalme","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqab133","article-title":"Histologic findings and tissue B-cell depletion in endoscopic mucosal biopsy specimens of the gastrointestinal tract after treatment with rituximab","volume":"157","author":"Kmeid","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2025.106025_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100770","article-title":"The histologic spectrum of rituximab-associated common variable immunodeficiency-like enteropathy","volume":"38","author":"Jafari","year":"2025","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2025.106025_bib52","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10620-025-08847-w","article-title":"Common variable immunodeficiency-like enteropathy associated with rituximab B-Cell depletion therapy","volume":"70","author":"Hakimian","year":"2025","journal-title":"Dig Dis Sci"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:37:33Z","timestamp":1772725053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"alternative-id":["S0046817725003120"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106025","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What's new in upper gastrointestinal pathology: Key updates and evolving challenges in 2026","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106025"}}